Global Erwinase Market Size, Share, Trends and Forecast 2022-2030

Description

Erwinase is used in combination with other anti-neoplastic agents to treat acute lymphoblastic leukaemia. It may also be used in other neoplastic conditions where depletion of asparagine might be expected to have a useful effect.
Industry Insights

Due to the COVID-19 pandemic, the global Erwinase market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Erwinase market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Erwinase landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Erwinase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. Erwinase® is indicated for the treatment of Acute Lymphoblastic Leukaemia (ALL), a type of cancer that particularly affects children. Erwinase® is an asparaginase enzyme derived from the bacterium Erwinia chrysanthemi that is used as part of the treatment protocols in conjunction with radiotherapy or chemotherapy. In the last several years, In the past few years, the market has been in a state of insufficient supply. The main reason is that the manufacturer's production status is not stable, and at the same time, some batches of drugs have been damaged due to the contamination of the site.Erwinase is widely sales for Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia and Others. The most proportion of Erwinase is sales in Acute Lymphoblastic Leukemia, and the consumption proportion is about 95% in 2019.

This report focuses on Erwinase volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Erwinase market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, China, Japan and South Korea, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Erwinase market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Acute Lymphoblastic Leukemia

Acute Myeloid Leukemia

Segment by Application

Child

Adult

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Jazz Pharmaceuticals/Porton Biopharma

Shire

Medac GmbH

Kyowa Hakko Kirin

Qianhong Bio-pharma

Taj Pharmaceuticals

Mingxing Pharma

SL Pharma

United Biotech

TABLE OF CONTENT

1 Erwinase Market Overview
1.1 Product Overview and Scope of Erwinase

1.2 Erwinase Segment by Type

1.2.1 Global Erwinase Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Acute Lymphoblastic Leukemia

1.2.3 Acute Myeloid Leukemia

1.3 Erwinase Segment by Application

1.3.1 Global Erwinase Sales Comparison by Application: (2022-2028)

1.3.2 Child

1.3.3 Adult

1.4 Global Erwinase Market Size Estimates and Forecasts

1.4.1 Global Erwinase Revenue 2017-2028

1.4.2 Global Erwinase Sales 2017-2028

1.4.3 Erwinase Market Size by Region: 2017 Versus 2021 Versus 2028

2 Erwinase Market Competition by Manufacturers

2.1 Global Erwinase Sales Market Share by Manufacturers (2017-2022)

2.2 Global Erwinase Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Erwinase Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Erwinase Manufacturing Sites, Area Served, Product Type

2.5 Erwinase Market Competitive Situation and Trends

2.5.1 Erwinase Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Erwinase Players Market Share by Revenue

2.5.3 Global Erwinase Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Erwinase Retrospective Market Scenario by Region

3.1 Global Erwinase Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Erwinase Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Erwinase Market Facts & Figures by Country

3.3.1 North America Erwinase Sales by Country

3.3.2 North America Erwinase Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Erwinase Market Facts & Figures by Country

3.4.1 Europe Erwinase Sales by Country

3.4.2 Europe Erwinase Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Erwinase Market Facts & Figures by Region

3.5.1 Asia Pacific Erwinase Sales by Region

3.5.2 Asia Pacific Erwinase Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Erwinase Market Facts & Figures by Country

3.6.1 Latin America Erwinase Sales by Country

3.6.2 Latin America Erwinase Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Erwinase Market Facts & Figures by Country

3.7.1 Middle East and Africa Erwinase Sales by Country

3.7.2 Middle East and Africa Erwinase Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Erwinase Historic Market Analysis by Type

4.1 Global Erwinase Sales Market Share by Type (2017-2022)

4.2 Global Erwinase Revenue Market Share by Type (2017-2022)

4.3 Global Erwinase Price by Type (2017-2022)

5 Global Erwinase Historic Market Analysis by Application

5.1 Global Erwinase Sales Market Share by Application (2017-2022)

5.2 Global Erwinase Revenue Market Share by Application (2017-2022)

5.3 Global Erwinase Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Jazz Pharmaceuticals/Porton Biopharma

6.1.1 Jazz Pharmaceuticals/Porton Biopharma Corporation Information

6.1.2 Jazz Pharmaceuticals/Porton Biopharma Description and Business Overview

6.1.3 Jazz Pharmaceuticals/Porton Biopharma Erwinase Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Jazz Pharmaceuticals/Porton Biopharma Erwinase Product Portfolio

6.1.5 Jazz Pharmaceuticals/Porton Biopharma Recent Developments/Updates

6.2 Shire

6.2.1 Shire Corporation Information

6.2.2 Shire Description and Business Overview

6.2.3 Shire Erwinase Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Shire Erwinase Product Portfolio

6.2.5 Shire Recent Developments/Updates

6.3 Medac GmbH

6.3.1 Medac GmbH Corporation Information

6.3.2 Medac GmbH Description and Business Overview

6.3.3 Medac GmbH Erwinase Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Medac GmbH Erwinase Product Portfolio

6.3.5 Medac GmbH Recent Developments/Updates

6.4 Kyowa Hakko Kirin

6.4.1 Kyowa Hakko Kirin Corporation Information

6.4.2 Kyowa Hakko Kirin Description and Business Overview

6.4.3 Kyowa Hakko Kirin Erwinase Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Kyowa Hakko Kirin Erwinase Product Portfolio

6.4.5 Kyowa Hakko Kirin Recent Developments/Updates

6.5 Qianhong Bio-pharma

6.5.1 Qianhong Bio-pharma Corporation Information

6.5.2 Qianhong Bio-pharma Description and Business Overview

6.5.3 Qianhong Bio-pharma Erwinase Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Qianhong Bio-pharma Erwinase Product Portfolio

6.5.5 Qianhong Bio-pharma Recent Developments/Updates

6.6 Taj Pharmaceuticals

6.6.1 Taj Pharmaceuticals Corporation Information

6.6.2 Taj Pharmaceuticals Description and Business Overview

6.6.3 Taj Pharmaceuticals Erwinase Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Taj Pharmaceuticals Erwinase Product Portfolio

6.6.5 Taj Pharmaceuticals Recent Developments/Updates

6.7 Mingxing Pharma

6.6.1 Mingxing Pharma Corporation Information

6.6.2 Mingxing Pharma Description and Business Overview

6.6.3 Mingxing Pharma Erwinase Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Mingxing Pharma Erwinase Product Portfolio

6.7.5 Mingxing Pharma Recent Developments/Updates

6.8 SL Pharma

6.8.1 SL Pharma Corporation Information

6.8.2 SL Pharma Description and Business Overview

6.8.3 SL Pharma Erwinase Sales, Revenue and Gross Margin (2017-2022)

6.8.4 SL Pharma Erwinase Product Portfolio

6.8.5 SL Pharma Recent Developments/Updates

6.9 United Biotech

6.9.1 United Biotech Corporation Information

6.9.2 United Biotech Description and Business Overview

6.9.3 United Biotech Erwinase Sales, Revenue and Gross Margin (2017-2022)

6.9.4 United Biotech Erwinase Product Portfolio

6.9.5 United Biotech Recent Developments/Updates

7 Erwinase Manufacturing Cost Analysis

7.1 Erwinase Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Erwinase

7.4 Erwinase Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Erwinase Distributors List

8.3 Erwinase Customers

9 Erwinase Market Dynamics

9.1 Erwinase Industry Trends

9.2 Erwinase Market Drivers

9.3 Erwinase Market Challenges

9.4 Erwinase Market Restraints

10 Global Market Forecast

10.1 Erwinase Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Erwinase by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Erwinase by Type (2023-2028)

10.2 Erwinase Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Erwinase by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Erwinase by Application (2023-2028)

10.3 Erwinase Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Erwinase by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Erwinase by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample